Bupropion 150 mg XL

DRUG2 trials

Conditions

Breast CarcinomaCervical CarcinomaHealthy Adult Male and Female VolunteersOvarian CarcinomaPostmenopausalUterine Corpus CancerVaginal CarcinomaVulvar Carcinoma

Phase 1

Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol

Not yet recruitingNCT07269873

BioCorRx Pharmaceuticals IncHealthy Adult Male and Female Volunteers

Start: 2026-01-13End: 2026-12-05Target: 30Updated: 2025-12-08

Phase 2

Bupropion Hydrochloride in Improving Sexual Desire in Women With Breast or Gynecologic Cancer

CompletedNCT03180294

NRG OncologyBreast Carcinoma, Cervical Carcinoma, Ovarian Carcinoma +4

Start: 2017-05-31End: 2021-02-22Updated: 2022-03-08

Related Papers

NRG-CC004 ancillary data study—exploring the effect of bupropion on sexual desire in female cancer survivors with and without vulvovaginal symptoms

The Journal of Sexual Medicine2024-06-10

Bupropion 150 mg XL

Sponsors

Conditions

Phase 1

Phase 2

Related Papers